Diabetes
From the Journals
Type 2 diabetes remission can happen naturally in 1 in 20
About 1 in 20 people in Scotland who had previously been diagnosed with type 2 diabetes were in remission in 2019, usually without a history of an...
Conference Coverage
Empagliflozin a winner in challenging arena of stabilized acute HF
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of...
Opinion
Case: Older patient with T2D has recurrent flushing
Learn four principles to help make diagnoses in challenging cases like this one.
Conference Coverage
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
From the Journals
Specific blood pressure-lowering drugs prevent onset of new diabetes
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers showed the strongest association with preventive effects.
Conference Coverage
ASCEND: Aspirin shows hint of dementia protection in T2D
Conference Coverage
Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
Secondary trial analyses in patients with type 2 diabetes showed both finerenone and sotagliflozin had heart failure benefits across the spectrum...
Conference Coverage
More STEP data: Semaglutide cuts weight, cravings, beats liraglutide
In STEP 5, weight loss with semaglutide was sustained at 2 years and the drug cut cravings in a subgroup; in STEP 8, semaglutide beat liraglutide...
Conference Coverage
AHA 2021 puts scientific dialogue, health equity center stage
The Scientific Sessions are fully online but with a heavy emphasis on live events and opportunities to interact globally over the latest...
Conference Coverage
Liraglutide effective against weight regain after gastric bypass
In a randomized controlled trial of patients who regained weight after a gastric bypass, 69% of patients given liraglutide lost at least 5% of...
Conference Coverage
Statins’ effects on CVD outweigh risk for diabetes in RA
A large cohort study reports that the cardiovascular benefits of statin use in people with rheumatoid arthritis outweigh the moderate diabetes...